The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine

被引:106
作者
Pelissier, T
Pajot, J
Dallel, R
机构
[1] Fac Chirurg Dent, Lab Physiol Oro Faciale, F-63000 Clermont Ferrand, France
[2] Univ Chile, Fac Med, Programa Farmacol Mol & Clinica, ICBM, Santiago, Chile
关键词
inflammation; nociception; opioid; grooming activity; trigeminal;
D O I
10.1016/S0304-3959(01)00432-8
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The aim of this study was to develop a rat model of capsaicin-induced pain in the orofacial region. We examined the effects of subcutaneous injection of different doses of capsaicin (0.25, 0.4. 0.8, 1.5, 2.5. 25. 50. 100, 500 mug) on the face-grooming response. Injection of capsaicin into the vibrissa pad produced an immediate grooming of the injected area with ipsilateral fore- or hindpaw. A positive relationship between the amplitude of (lie grooming response and the capsaicin dose was observed until 1.5 V,a, but with the highest concentrations (ranging from 25 to 500 mug) the amplitude of the response decreased. Morphine administered either systemically (in the neck, 0.5-4.0 mg/ka) or locally (0.25-1.0 mg/kg) reduced in a dose-dependent fashion the face grooming provoked by subcutaneous capsaicin (1.5 mug). The systemic and local morphine effects could be reversed by systemic (10.1 mg/kg) and local (0.05 mg/kg) administration of naloxone, respectively. The local administration of morphine (ED50: 0,65 mg/kg) was more potent than systemic injection (ED50: 2.54 mg/ kg) in reducing the grooming behavior. In conclusion, the orofacial capsaicin test appears to be a valid and reliable method for studying trigeminal pain mechanisms and testing analgesic drugs. The results of the present study also support the clinical use of peripheral opioid administration for the treatment of orofacial painful conditions. (C) 2002 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 51 条
  • [41] SCHAAFSMA L, 1997, AM J PHYSIOL, V272, P76
  • [42] INFLAMMATION ENHANCES PERIPHERAL MU-OPIOID RECEPTOR-MEDIATED ANALGESIA, BUT NOT MU-OPIOID RECEPTOR TRANSCRIPTION IN DORSAL-ROOT GANGLIA
    SCHAFER, M
    IMAI, Y
    UHL, GR
    STEIN, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 279 (2-3) : 165 - 169
  • [43] NEUROGENIC HYPERALGESIA - CENTRAL NEURAL CORRELATES IN RESPONSES OF SPINOTHALAMIC TRACT NEURONS
    SIMONE, DA
    SORKIN, LS
    OH, U
    CHUNG, JM
    OWENS, C
    LAMOTTE, RH
    WILLIS, WD
    [J]. JOURNAL OF NEUROPHYSIOLOGY, 1991, 66 (01) : 228 - 246
  • [44] Simone DA, 1998, J NEUROSCI, V18, P8947
  • [45] DOSE-DEPENDENT PAIN AND MECHANICAL HYPERALGESIA IN HUMANS AFTER INTRADERMAL INJECTION OF CAPSAICIN
    SIMONE, DA
    BAUMANN, TK
    LAMOTTE, RH
    [J]. PAIN, 1989, 38 (01) : 99 - 107
  • [46] PERIPHERAL OPIOID RECEPTORS
    STEIN, C
    SCHAFER, M
    HASSAN, AHS
    [J]. ANNALS OF MEDICINE, 1995, 27 (02) : 219 - 221
  • [47] STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269
  • [48] Szallasi A, 1999, PHARMACOL REV, V51, P159
  • [49] VOS BP, 1994, J NEUROSCI, V14, P2708
  • [50] ETHICAL GUIDELINES FOR INVESTIGATIONS OF EXPERIMENTAL PAIN IN CONSCIOUS ANIMALS
    ZIMMERMANN, M
    [J]. PAIN, 1983, 16 (02) : 109 - 110